Citadel Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Sell
43,402
-823,318
-95% -$49.4M ﹤0.01% 5820
2025
Q4
$51M Buy
866,720
+649,541
+299% +$39.5M 0.01% 1394
2025
Q3
$12.1M Sell
217,179
-2,253,683
-91% -$121M ﹤0.01% 2982
2025
Q2
$127M Buy
2,470,862
+2,011,189
+438% +$101M 0.02% 613
2025
Q1
$27M Sell
459,673
-1,298,401
-74% -$88M 0.01% 1702
2024
Q4
$127M Buy
1,758,074
+553,590
+46% +$40.7M 0.02% 611
2024
Q3
$96.3M Buy
1,204,484
+946,543
+367% +$71.1M 0.02% 721
2024
Q2
$18.5M Buy
257,941
+156,876
+155% +$11.5M ﹤0.01% 2073
2024
Q1
$7.11M Buy
+101,065
New +$7.23M ﹤0.01% 3417
2023
Q4
Sell
-312,533
Closed -$20.6M 15246
2023
Q3
$21.3M Buy
312,533
+206,426
+195% +$16.3M ﹤0.01% 1795
2023
Q2
$8.66M Sell
106,107
-446,457
-81% -$35.9M ﹤0.01% 2868
2023
Q1
$41M Buy
552,564
+510,677
+1,219% +$39.4M 0.01% 1244
2022
Q4
$3.47M Sell
41,887
-427,841
-91% -$34M ﹤0.01% 4514
2022
Q3
$33.4M Buy
469,728
+439,924
+1,476% +$38M 0.01% 1382
2022
Q2
$2.58M Sell
29,804
-171,548
-85% -$16.1M ﹤0.01% 5038
2022
Q1
$21.8M Buy
201,352
+195,960
+3,634% +$20.2M ﹤0.01% 1886
2021
Q4
$698K Sell
5,392
-83,988
-94% -$10.3M ﹤0.01% 8851
2021
Q3
$10.8M Buy
89,380
+9,940
+13% +$1.21M ﹤0.01% 2950
2021
Q2
$8.94M Buy
79,440
+75,332
+1,834% +$7.93M ﹤0.01% 3259
2021
Q1
$392K Sell
4,108
-70,036
-94% -$6.39M ﹤0.01% 10231
2020
Q4
$5.89M Buy
74,144
+34,104
+85% +$2.47M ﹤0.01% 3412
2020
Q3
$2.48M Sell
40,040
-185,744
-82% -$12.1M ﹤0.01% 4322
2020
Q2
$14.9M Buy
225,784
+190,012
+531% +$11.4M 0.01% 1783
2020
Q1
$1.7M Sell
35,772
-202,296
-85% -$10.1M ﹤0.01% 4415
2019
Q4
$13.1M Buy
238,068
+208,300
+700% +$10.9M 0.01% 1929
2019
Q3
$1.46M Sell
29,768
-289,612
-91% -$14.5M ﹤0.01% 4970
2019
Q2
$16.6M Sell
319,380
-137,220
-30% -$6.91M 0.01% 1606
2019
Q1
$22.7M Buy
456,600
+295,336
+183% +$13.3M 0.01% 1227
2018
Q4
$5.83M Buy
161,264
+4,292
+3% +$179K ﹤0.01% 2565
2018
Q3
$8.01M Sell
156,972
-50,392
-24% -$2.23M ﹤0.01% 2400
2018
Q2
$7.67M Sell
207,364
-71,800
-26% -$2.74M ﹤0.01% 2228
2018
Q1
$10.5M Sell
279,164
-1,387,780
-83% -$49M 0.01% 1681
2017
Q4
$54M Buy
1,666,944
+372,700
+29% +$11.8M 0.03% 577
2017
Q3
$39.1M Buy
1,294,244
+2,268
+0.2% +$67.3K 0.03% 672
2017
Q2
$38M Buy
1,291,976
+184,928
+17% +$5.05M 0.03% 626
2017
Q1
$28.1M Buy
1,107,048
+507,884
+85% +$13.1M 0.03% 753
2016
Q4
$15.4M Buy
599,164
+94,792
+19% +$2.49M 0.02% 1049
2016
Q3
$13.8M Buy
504,372
+213,152
+73% +$5.85M 0.01% 1099
2016
Q2
$8.21M Buy
291,220
+19,844
+7% +$510K 0.01% 1398
2016
Q1
$6.41M Sell
271,376
-35,416
-12% -$780K 0.01% 1551
2015
Q4
$6.9M Buy
306,792
+1,892
+0.6% +$43.1K 0.01% 1543
2015
Q3
$7.05M Sell
304,900
-91,044
-23% -$2.28M 0.01% 1608
2015
Q2
$9.75M Sell
395,944
-146,440
-27% -$3.66M 0.01% 1493
2015
Q1
$13.6M Sell
542,384
-135,020
-20% -$3.21M 0.01% 1226
2014
Q4
$15.6M Sell
677,404
-224,924
-25% -$5.15M 0.02% 1107
2014
Q3
$21.1M Sell
902,328
-302,404
-25% -$7.09M 0.02% 872
2014
Q2
$27.9M Buy
1,204,732
+148,072
+14% +$3.27M 0.03% 636
2014
Q1
$22.6M Buy
1,056,660
+222,204
+27% +$5M 0.03% 760
2013
Q4
$19.8M Buy
834,456
+46,868
+6% +$1.02M 0.03% 808
2013
Q3
$15.8M Sell
787,588
-213,224
-21% -$4.05M 0.02% 828
2013
Q2
$17.3M Buy
+1,000,812
New +$16.6M 0.03% 738

Other funds holding TECH

Citadel Advisors's TECH Position: Q1 2026 in Review

Citadel Advisors reduced its Bio-Techne (TECH) stake by 95% in Q1 2026, selling an estimated $49.4M and leaving 43,402 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #5820.

Citadel Advisors first reported a position in TECH in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q2 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Citadel Advisors held 43,402 shares of Bio-Techne worth $2.27M as of Q1 2026.
  • Citadel Advisors sold 823,318 Bio-Techne shares in Q1 2026, an estimated $49.4M.
  • Bio-Techne made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5820 holding.
  • Citadel Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Bio-Techne position peaked at $127M in Q2 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.